Correction to "Teneligliptin mitigates diabetic cardiomyopathy by inhibiting activation of the NLRP3 inflammasome".

IF 5.1 3区医学 Q1 ENDOCRINOLOGY & METABOLISM

World Journal of Diabetes Pub Date : 2026-09-15 DOI:10.4239/wjd.124151

Gu-Lao Zhang, Zhen-Huan Chen

引用次数: 0

Abstract

[This corrects the article DOI: 10.4239/wjd.v15.i4.724.][This corrects the article on p. 724 in vol. 15, PMID: 38680706.].

查看原文本刊更多论文

更正“替尼格列汀通过抑制NLRP3炎性体的激活来减轻糖尿病性心肌病”。

[这更正了文章DOI: 10.4239/wjd.v15.i4.724。][这更正了第15卷第724页的文章，PMID: 38680706]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

World Journal of Diabetes ENDOCRINOLOGY & METABOLISM-

自引率

2.40%

发文量

909

期刊介绍： The WJD is a high-quality, peer reviewed, open-access journal. The primary task of WJD is to rapidly publish high-quality original articles, reviews, editorials, and case reports in the field of diabetes. In order to promote productive academic communication, the peer review process for the WJD is transparent; to this end, all published manuscripts are accompanied by the anonymized reviewers’ comments as well as the authors’ responses. The primary aims of the WJD are to improve diagnostic, therapeutic and preventive modalities and the skills of clinicians and to guide clinical practice in diabetes. Scope: Diabetes Complications, Experimental Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus, Diabetes, Gestational, Diabetic Angiopathies, Diabetic Cardiomyopathies, Diabetic Coma, Diabetic Ketoacidosis, Diabetic Nephropathies, Diabetic Neuropathies, Donohue Syndrome, Fetal Macrosomia, and Prediabetic State.